InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Amneal Pharmaceuticals, Inc.

AMRX Clue Score38
Fiscal year ends December CIK 0001723128
$19.91 +1.32% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $19.91 +240.92% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue1,018.2Operating income284.9Net income0.0Fiscal year 2017Revenue1,033.7 +1.5%Operating income245.1Net income0.0Fiscal year 2018Revenue1,663.0 +60.9%Operating income−19.7Net income−19.7EPS, diluted−0.16Fiscal year 2019Revenue1,626.4 −2.2%Operating income−248.7Net income−603.6EPS, diluted−2.74Fiscal year 2020Revenue1,992.5 +22.5%Operating income91.2Net income67.8EPS, diluted0.61Fiscal year 2021Revenue2,093.7 +5.1%Operating income152.7Net income13.2 −80.6%EPS, diluted0.07Fiscal year 2022Revenue2,212.3 +5.7%Operating income−94.9Net income−270.6 −2,155.6%EPS, diluted−0.86Fiscal year 2023Revenue2,393.6 +8.2%Operating income204.4Net income−84.0EPS, diluted−0.48Fiscal year 2024Revenue2,794.0 +16.7%Operating income249.3Net income−116.9EPS, diluted−0.38Fiscal year 2025Revenue3,018.8 +8.0%Operating income394.1Net income72.1EPS, diluted0.22
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 1,018.2 1,033.7 1,663.0 1,626.4 1,992.5 2,093.7 2,212.3 2,393.6 2,794.0 3,018.8
Growth +1.5% +60.9% −2.2% +22.5% +5.1% +5.7% +8.2% +16.7% +8.0%
Operating income 284.9 245.1 −19.7 −248.7 91.2 152.7 −94.9 204.4 249.3 394.1
Net income 0.0 0.0 −19.7 −603.6 67.8 13.2 −270.6 −84.0 −116.9 72.1
Growth −80.6% −2,155.6%
EPS, diluted n/a n/a −0.16 −2.74 0.61 0.07 −0.86 −0.48 −0.38 0.22

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Gross margin58.7%Operating margin28.0%Net margin0.0%Free cash flow margin−0.8%Fiscal year 2017Gross margin50.9%Operating margin23.7%Net margin0.0%Free cash flow margin13.5%Fiscal year 2018Gross margin43.1%Operating margin−1.2%Net margin−1.2%Free cash flow margin10.1%Fiscal year 2019Gross margin21.7%Operating margin−15.3%Net margin−37.1%Free cash flow margin−2.8%Fiscal year 2020Gross margin31.5%Operating margin4.6%Net margin3.4%Free cash flow margin16.2%Fiscal year 2021Gross margin36.7%Operating margin7.3%Net margin0.6%Free cash flow margin9.3%Fiscal year 2022Gross margin35.5%Operating margin−4.3%Net margin−12.2%Free cash flow margin0.8%Fiscal year 2023Gross margin34.3%Operating margin8.5%Net margin−3.5%Free cash flow margin12.6%Fiscal year 2024Gross margin36.5%Operating margin8.9%Net margin−4.2%Free cash flow margin8.7%Fiscal year 2025Gross margin36.9%Operating margin13.1%Net margin2.4%Free cash flow margin8.9%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 58.7% 50.9% 43.1% 21.7% 31.5% 36.7% 35.5% 34.3% 36.5% 36.9%
Operating margin 28.0% 23.7% −1.2% −15.3% 4.6% 7.3% −4.3% 8.5% 8.9% 13.1%
Net margin 0.0% 0.0% −1.2% −37.1% 3.4% 0.6% −12.2% −3.5% −4.2% 2.4%
Free cash flow margin −0.8% 13.5% 10.1% −2.8% 16.2% 9.3% 0.8% 12.6% 8.7% 8.9%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow115.1Capital expenditure−122.8Free cash flow−7.7Dividends paid−200.6Fiscal year 2017Operating cash flow234.2Capital expenditure−94.8Free cash flow139.4Dividends paid−375.3Fiscal year 2018Operating cash flow250.2Capital expenditure−83.1Free cash flow167.1 +19.9%Dividends paid−183.0Fiscal year 2019Operating cash flow1.7Capital expenditure−47.2Free cash flow−45.5 −127.2%Dividends paid0.0Fiscal year 2020Operating cash flow379.0Capital expenditure−56.4Free cash flow322.6Dividends paid0.0Fiscal year 2021Operating cash flow241.8Capital expenditure−47.7Free cash flow194.1 −39.8%Fiscal year 2022Operating cash flow65.1Capital expenditure−46.4Free cash flow18.7 −90.4%Fiscal year 2023Operating cash flow345.6Capital expenditure−43.2Free cash flow302.4 +1,517.5%Fiscal year 2024Operating cash flow295.1Capital expenditure−51.9Free cash flow243.2 −19.6%Fiscal year 2025Operating cash flow340.0Capital expenditure−70.1Free cash flow269.9 +11.0%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 115.1 234.2 250.2 1.7 379.0 241.8 65.1 345.6 295.1 340.0
Capital expenditure −122.8 −94.8 −83.1 −47.2 −56.4 −47.7 −46.4 −43.2 −51.9 −70.1
Free cash flow −7.7 139.4 167.1 −45.5 322.6 194.1 18.7 302.4 243.2 269.9
Growth +19.9% −127.2% −39.8% −90.4% +1,517.5% −19.6% +11.0%
Dividends paid −200.6 −375.3 −183.0 0.0 0.0 n/a n/a n/a n/a n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash27.4Fiscal year 2017Cash74.2Total debt1,444.4Net cash (debt)−1,370.3Shareholders’ equity0.0Fiscal year 2018Cash213.4Total debt2,652.0Net cash (debt)−2,438.7Shareholders’ equity504.8Debt to equity5.25Fiscal year 2019Cash151.2Total debt2,630.5Net cash (debt)−2,479.3Shareholders’ equity232.0Debt to equity11.34Fiscal year 2020Cash341.4Total debt2,779.5Net cash (debt)−2,438.1Shareholders’ equity303.3Debt to equity9.17Fiscal year 2021Cash247.8Total debt2,710.7Net cash (debt)−2,462.9Shareholders’ equity360.3Debt to equity7.52Fiscal year 2022Cash26.0Total debt2,621.9Net cash (debt)−2,596.0Shareholders’ equity298.4Debt to equity8.79Fiscal year 2023Cash91.5Total debt2,420.1Net cash (debt)−2,328.6Shareholders’ equity19.8Debt to equity122.35Fiscal year 2024Cash110.6Total debt2,386.0Net cash (debt)−2,275.5Shareholders’ equity−109.3Fiscal year 2025Cash282.0Total debt2,571.9Net cash (debt)−2,289.8Shareholders’ equity−70.8
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 27.4 74.2 213.4 151.2 341.4 247.8 26.0 91.5 110.6 282.0
Total debt n/a 1,444.4 2,652.0 2,630.5 2,779.5 2,710.7 2,621.9 2,420.1 2,386.0 2,571.9
Net cash (debt) n/a −1,370.3 −2,438.7 −2,479.3 −2,438.1 −2,462.9 −2,596.0 −2,328.6 −2,275.5 −2,289.8
Shareholders’ equity n/a 0.0 504.8 232.0 303.3 360.3 298.4 19.8 −109.3 −70.8
Debt to equity n/a n/a 5.25 11.34 9.17 7.52 8.79 122.35 n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Margins
58.7% 50.9% 43.1% 21.7% 31.5% 36.7% 35.5% 34.3% 36.5% 36.9%
28.0% 23.7% −1.2% −15.3% 4.6% 7.3% −4.3% 8.5% 8.9% 13.1%
21.1% 16.6% −12.2% −13.5% −1.8% 1.5% −11.2% −1.7% −2.0% 4.6%
0.0% 0.0% −1.2% −37.1% 3.4% 0.6% −12.2% −3.5% −4.2% 2.4%
−0.8% 13.5% 10.1% −2.8% 16.2% 9.3% 0.8% 12.6% 8.7% 8.9%
Spending
17.6% 16.6% 11.7% 11.6% 9.0% 9.6% 8.8% 6.8% 6.8% 6.2%
11.7% 10.5% 13.7% 17.8% 16.4% 17.5% 18.1% 18.0% 17.1% 17.5%
12.1% 9.2% 5.0% 2.9% 2.8% 2.3% 2.1% 1.8% 1.9% 2.3%
2.5% 1.2% n/a n/a n/a 35.7% n/a n/a n/a 8.1%
Returns
n/a n/a −3.9% −260.1% 22.4% 3.7% −90.7% −424.6% n/a n/a
n/a 0.0% −0.5% −16.5% 1.7% 0.3% −7.1% −2.4% −3.3% 2.0%
Balance and payout
n/a n/a 5.25 11.34 9.17 7.52 8.79 122.35 n/a n/a
n/a 0.0% n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a 0.0% n/a n/a n/a n/a n/a
n/a 269.2% 109.5% n/a 0.0% n/a n/a n/a n/a n/a